The novel treatment of tirzepatide peptide represents a significant breakthrough in the handling of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide313547.azzablog.com/42456667/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment